Source · Select Committees · Health and Social Care Committee
Recommendation 23
23
Paragraph: 123
Review dermal filler licensing to make them prescription-only substances, like Botox.
Recommendation
We recommend that the Department review the licencing of dermal fillers to be prescription-only substances, in line with Botox, in order to provide more protection for people undertaking procedures involving dermal fillers.
Paragraph Reference:
123
Government Response
A response document is linked to this report, dated 7 February 2023. Response attribution to this recommendation has not been verified. Read the response document ↗